Literature DB >> 23889765

Mortality associated with alcohol-related liver disease.

G Trimble1, L Zheng, A Mishra, S Kalwaney, H M Mir, Z M Younossi.   

Abstract

BACKGROUND: Excessive alcohol use has been reported to be responsible for 80 000 annual deaths in the United States. However, the exact cause of death related to the excessive use of alcohol has not been fully explored. AIM: To assess the effect of alcoholic liver disease (ALD) on all-cause, liver-related and cardiovascular mortality using population-based data.
METHODS: Data were obtained from the Third National Health and Nutrition Examination Survey (NHANES III) Linked Mortality Files. Alcohol consumption was estimated as grams per day. Multivariate Cox proportional hazards model was utilised to assess the effects of ALD on follow-up time to mortality from all causes, cardiovascular disease and liver disease.
RESULTS: A total of 8,306 participants were included [ALD (n = 148)]. Mortality follow-up data were available for a median time of 178.27 months. Participants with ALD had increased risk for liver-related mortality [adjusted hazard ratios or aHR 7.06 (2.09-23.79)], but not for overall mortality [aHR 1.14 (0.70-1.85)] or cardiovascular mortality [aHR 0.61 (0.11-3.25)].
CONCLUSION: Alcoholic liver disease increases the risks for liver-related mortality but not for cardiac or overall mortality.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23889765     DOI: 10.1111/apt.12432

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

1.  Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.

Authors:  Iliana Doycheva; Kymberly D Watt; Ghassoub Rifai; Rachel Abou Mrad; Rocio Lopez; Nizar N Zein; William D Carey; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

2.  Exhaled Nitric Oxide Levels Among Adults With Excessive Alcohol Consumption.

Authors:  Majid Afshar; Jill A Poole; Guichan Cao; Ramon Durazo; Richard C Cooper; Elizabeth J Kovacs; Joseph H Sisson
Journal:  Chest       Date:  2016-02-19       Impact factor: 9.410

Review 3.  Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Nobuyuki Toshikuni; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

4.  Liver tissue metabolically transformed by alcohol induces immune recognition of liver self-proteins but not in vivo inflammation.

Authors:  Michael J Duryee; Benjamin M Wiese; Jordan R Bowman; Jared D Vanlandingham; Lynell W Klassen; Geoffrey E Thiele; Carlos D Hunter; Daniel R Anderson; Ted R Mikuls; Geoffrey M Thiele
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-12-28       Impact factor: 4.052

Review 5.  Diagnosis of alcoholic liver disease.

Authors:  Cara Torruellas; Samuel W French; Valentina Medici
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

6.  Development and validation of a composite score for excessive alcohol use screening.

Authors:  Wanzhu Tu; Chenghao Chu; Shanshan Li; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-03-21       Impact factor: 2.895

7.  Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Nobuyuki Toshikuni; Mutsumi Tsuchishima; Atsushi Fukumura; Tomiyasu Arisawa; Mikihiro Tsutsumi
Journal:  Gastroenterol Res Pract       Date:  2017-08-22       Impact factor: 2.260

8.  Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States.

Authors:  James M Paik; Pegah Golabi; Rakesh Biswas; Saleh Alqahtani; Chapy Venkatesan; Zobair M Younossi
Journal:  Hepatol Commun       Date:  2020-04-04

9.  Disability Status, Unemployment, and Alcohol-Related Liver Disease (ALD) Mortality: A Large Sample Individual Level Longitudinal Study.

Authors:  Augustine J Kposowa; Kevin Breault
Journal:  Subst Abuse Rehabil       Date:  2021-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.